Abstract
People are using medicinal plants for many decades for wellbeing, effectiveness, nativity, and reduced side effects. Herbs and herbal products partake been applied with evidence base to treat and avoid ailments all over times past. Written palm leaf manuscripts and literature about medicinal plants available in Sangam period age about 5000 years compare to the Sumerians and earliest records are recommended prior use of therapeutic plants in Siddha medicine. Due to adverse effects of synthetic products, in attendance is a shift towards AYUSH therapies and medicinal plants. However, share of global market by Indians in medicinal plants related to economy has not reached its mark due to lack of translation as products existing in another arena. This chapter deals about positioning India in world market and attempts to deal about areas where the strength of Siddha prevails to translate knowledge from the lab to layman as products.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Anonyms. Good Clinical Practice Guidelines for Clinical Trials in Ayurveda, Siddha and Unani Medicine (GCP – ASU). New Delhi: Department of AYUSH, Ministry of Health and Family Welfare, Government of India; 2013.
Auerbach. Bioaccumulation of polyacrylamide aromatic compounds: 2. Modelling bioaccumulation in marine organisms chronically exposed to dispersed oil. Environ Toxicol Chem. 1947;20:1185–95.
Ayurvedic Pharmacopoeia of India Part-I, V-II, V-I. Ministry of AYUSH, Govt of India. 1st ed. 1999.
Ayurvedic pharmacopoeia of India Part-I, Ministry of AYUSH, Govt of India. 2001a.
Ayurvedic Pharmacopoeia of India Part-II, V-III. Ministry of AYUSH, Govt of India. 1st ed. 2001b.
Ayurvedic Pharmacopoeia of India Part-I, V-IV. Ministry of AYUSH, Govt of India. 1st ed. 2004.
Ayurvedic Pharmacopoeia of India Part-I, V-V. Ministry of AYUSH, Govt of India. 1st ed. 2006.
Ayurvedic Pharmacopoeia of India Part-II, V-III. (Form.), Ministry of AYUSH, Govt of India. 1st ed. 2008.
Ayurvedic Pharmacopoeia of India Part-I, V-VI. Ministry of AYUSH, Govt of India. 1st ed. 2009.
Ayurvedic Pharmacopoeia of India Part-II, V-I. Ministry of AYUSH, Govt of India. 1st ed. 2016.
Biodiversity Act. 2011. http://www.moef.nic.in/modules/rules-and-regulation/bio-diversity/. Accessed 03 Oct 2011.
Dept. of AYUSH. Macroscopic and microscopic atlas of Pharmacopoeial drugs part- I, V-V. Ministry of Health and Family Welfare, Govt of India. 2016.
Fitzgerald GA. Opinion, anticipating change in drug development, the emerging era of translational medicine and therapeutics. Nat Rev Drug Discov. 2005;4(10):815–8.
Folashade KO, Omoregie HE, Ochogu AP. Standardization of herbal medicines – a review. Int J Biodivers Conserv. 2012;4:101–12.
Joshi K, Chavan P, Warde D, Patwardhan B. Molecular markers in herbal drug technology. Curr Sci. 2004;87:159.
Kataria S, Bhardwaj S, Middha A. Standardization of medicinal plant material. Int J Res Ayurveda Pharm. 2011;2(4):1100–9.
Kochhar SL. Tropical crops: a textbook of economy botany. London: Macmillan Pub Ltd; 1981.
Lauer MS, Skarlatos S. Translational research for cardiovascular diseases at the National Heart, Lung, and Blood Institute, moving from bench to bedside and from bedside to community. Circulation. 2010;121(7):929–33.
Mittal BM. A textbook of forensic pharmacy. Delhi: Vallabh Prakashan; 2007. p. 73–143.
Moef. 2011. http://www.moef.nic.in/modules/rules-and-regulation/wildlife/. Accessed 02 Oct 2011.
Paterson NE. Translational research in addiction, toward a framework for the development of novel therapeutics. Biochem Pharmacol. 2011;81:1388–407.
Pharmacopoeia Commission for Indian Medicine & Homoeopathy. TLC Atlas Part-I, V-I, Ministry of AYUSH, Govt of India. 2016.
Prestone RJ, Hoffmann GR. Genetic toxicology. In: Klaassen CD, editor. Casarette and Doull’s toxicology, the basic science of poison. 6th ed. New York: McGraw- Hill Medical Publishing Division; 2001.. https://accesspharmacy.mhmedical.com/content.aspx?sectionid=53483730&bookid=958.
Sharma SK. Infrastructure status, regulation & quality control of Indian medicine. Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha, Homoeopath (AYUSH). New Delhi: Ministry of Health & Family Welfare, Government of India; 2006.
Simon R. Translational research in oncology, key bottlenecks and new paradigms. Expert Rev Mol Med. 2010;12:e32.
Singh H. Prospects and challenges for harnessing opportunities in medicinal plants sector in India. LEAD J. 2006;2:198–211.
The Biological Diversity Act. 2002. http://www.genecampaign.org/home/Biological%20Diversity%20Act%202002.pdf. Accessed 01 Oct 2011.
The Drugs and Cosmetics Act and Rules, Government of India Ministry of Health and Family Welfare. 2011. http://www.cdsco.nic.in/html/copy%20of%201.%20dandcact121.pdf. Accessed 01 Oct 2011.
The Siddha Pharmacopoeia of India Part-1, V-I. Ministry of AYUSH, Govt of India. 1st ed. 2008.
The Wildlife (Protection) Act, Part- I 1972 with the Wildlife (protection) Amendment Act. 1972. http://www.westbengalforest.gov.in/pdf/the_wildlife_p_act_1972.pdf. Accessed 05 Jan 2012.
Unani Pharmacopoeia of India Part-II, V-I. Ministry of AYUSH, Govt of India. 2016.
Vaidya ADB, Devasagayam TPA. Current status of herbal drugs in India: an overview. J Clin Biochem Nutr. 2007;4:1–11.
Verma R. Drug regulations and plant-based pharmaceuticals in post. Izatnagar: Indian Veterinary Research Institute; 2006.
Von Herrath M, Chan A. How can we improve the translational landscape for a faster cure of type 1 diabetes? J Clin Invest. 2009;119(5):1061–5.
Wakdikar S. Global health care challenge: Indian experiences and new prescriptions. Electron J Biotechnol. 2004;7:214–20.
Wang PS, Heinssen R, Oliveri M, Wagner A, Goodman W. Bridging bench and practice, translational research for schizophrenia and other psychotic disorders. Neuropsychopharmacology. 2009;34(1):204–12.
WHO. Quality assurance of pharmaceuticals: a compendium of guidelines and related materials, good manufacturing practices and inspection. Geneva: World Health Organization; 1996a.
WHO. Guidelines for the Assessment of Herbal Medicines. In: WHO Technical Report Series. Geneva: World Health Organization; 1996b.
WHO. WHO Guidelines for the Regulation of Herbal Medicines in the South East Asia Region. 2003. http://apps.who.int/medicinedocs/en/m/abstract/Js22299en/.
Wildlife (Protection) Act. 2011. http://www.legalserviceindia.com/articles/wild.htm. Accessed 11 Oct 2011.
Working Group on “Access to Health Systems including AYUSH,” Government of India Planning Commission. Eleventh Five-year Plan (2007–2012) [homepage on the Internet]. 2012. http://planningcommission.nic.in/plans/planrel/11thf.htm. Accessed 20 Mar 2012.
World Health Organization. Traditional medicine, fact sheet no. 134 [homepage on the Internet]. 2012. http://www.who.int/mediacentre/factsheets/fs134/en/. Accessed 20 Mar 2012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kannan, M., Sathiyarajeswaran, P., Shree Devi, M.S. (2020). Translation of Traditional Knowledge from Lab to Layman from Herbal Sources. In: Sen, S., Chakraborty, R. (eds) Herbal Medicine in India. Springer, Singapore. https://doi.org/10.1007/978-981-13-7248-3_37
Download citation
DOI: https://doi.org/10.1007/978-981-13-7248-3_37
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7247-6
Online ISBN: 978-981-13-7248-3
eBook Packages: MedicineMedicine (R0)